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Abstract

Research Question

Discussion

• Acute Retinal Necrosis (ARN) can have extremely
devastating effects on the vision of both healthy and
immunocompromised individuals. Many times the
exact pathogen of ARN can remain a mystery due to
its silent and sometimes sudden onset along with the
loss of vision prior to vitreal biopsy. One of the known
pathogens is the Herpes Zoster Virus (HZV).
• When Herpes Zoster Virus attack the retina, there are
very devastating effects due to ARN including long
term complications and blindness. A review of
literature looked at the retrospective studies related to
the incidence and prevalence of ARN caused by HZV.
With an incidence of 1 case per 1.6 – 2.0 million
population per year (Papageorgiou, Ch'ng, Kulkarni,
Anwar, & Empeslidis, 2014), Acute Retinal Necrosis
(ARN) can have extremely devastating effects on the
vision of both healthy and immunocompromised
individuals. A correlation of ARN and HZV might
explain the complications and treatments related to
herpes zoster of the retina. The results show how
multiple healthcare providers can quickly identify and
seek specialized treatment to preserve the patient’s
eye site. These results indicate that there are more
detrimental eye related conditions that are associated
with herpes zoster virus than previously thought and
how seeking coordinated specialized treatment can
minimize the long term complications.

• In adult patients with sudden onset visual
disturbances caused by acute viral retinitis, does
immediate surgical intervention along with an antiviral
agent have a more favorable outcome than antiviral
agents alone.

• When a patient is presenting with signs of Acute Retinal
Necrosis, there will need to be a rapid treatment course in
order to preserve the patient’s long term visual outcome.

Introduction
• Herpes Zoster Virus (HZV) of the retina is a painless
process that can progress very rapidly. HZV attacking the
retina leads to Acute Retinal Necrosis (ARN) causing very
devastating effects risking both the short term and long
term outcomes of a patient’s visual acuity.

Statement of the Problem
• Acute Retinal Necrosis can be a devastating disease that
can lead to very dramatic lifestyle changes due to
permeant vision deficit and/or loss. The disease can show
up suddenly and progress very rapidly as well. Some of
its early onset of symptoms could potentially be dismissed
to age related visual changes from posterior vitreal
detachment, however on fundal exam changes to the
retina can be spotted leading the provider to take some
prompt action. There is some speculation that some
sudden vision loss in the adult population can be
associated to ARN in patients that never received eye
exams until after the retina had detached completely.

Literature Review
• Reviewing the literature, shows that the earlier the patient is
evaluated and the referral to an ophthalmologists that
specializes in disorders of the posterior aspect of the eye, the
patient will have a more favorable outcome. The longer the
patient is delayed in their treatment, the more damage will be
done to the retina decreasing the best visual acuity in the long
term.
• Cochran et al, 2011, is a 14 month prospective study that was
performed by the British Ophthalmological Surveillance Unit in
order to find the incidence of ARN. With the 45 patients that
were reported, 38 experienced unilateral involvement. 7 had
bilateral involvement either simultaneously or experienced
second eye involvement within a 3 month period after the initial
presentation. The most common causative agent in the ARN
was reported to be Varicella Zoster Virus. Other causative
agents include CMV, HSV 1 & 2, VZV, toxoplasmosis, EpsteinBarr virus, and Syphilis.
• Testing that can be performed for the confirmation of the virus
that is the most common causes for ARN is polymerase chain
reaction (PCR) of a small amount of vitreous fluid (Takase et al.,
2015) under general anesthesia in a surgical suite.
• However the exact causative agent is not necessary for
treatment as the treatments are the same. Virostatic drugs
should be started immediately and then corticosteroids should
be added no earlier than 24-48 hours after the antiviral
medications. (Mach et al., 2012)
• Roy et al., 2014, is a study of that was done retrospectively
over a 10 year period with a total of 62 eyes out of 53 patients
diagnosed with ARN. The outcomes varied with all of the
patients started immediately on antiviral therapy, both oral and
intravenous and was followed by a course of oral steroids. The
final viral diagnosis was HSV in 19 patients (30.60%) and VZV
in 28 (45.16%). There was retinal detachment in 66.12 % (41
eyes). Favorable final outcomes were seen in 28 of the 62 eyes
(45.1%). The treatment needs to be quick and aggressive to
increase the rates of the favorable outcome of ARN, a fulminate
disorder. (Roy et al., 2014)).

• The course of this treatment will not be one that will only
require a few days of treatment, this will be a treatment
course that will require dedication and patience on both
the patient as well as the provider as this may last for
months to years. Depending on the causative agent, there
may be relapses from time to time that will require need
for immediate evaluation and possible treatment.
• The vitreous inflammation that occurs in these relapses
increases the intraocular pressure causing several other
ocular problems. These problems include but not limited
to optic nerve damage, posterior subcapsular cataract
(PSC) formation, cystoid macular edema (CME), and
vasculitis associated macular degeneration

Applicability to Clinical
Practice
• How a PCP would initially suspect would be a patient that
is seen in the office for visual changes in one or both eyes
with or without a minimal amount of pain, anterior uvulitis,
or a rapid increase in number or the new presence of
“floaters” in the eye.
• As a primary care provider, a call to an ophthalmologist
needs to be made quickly when there is any suspicion of
Acute Retinal Necrosis. This call should include questions
in regards to the diagnostic studies that the
ophthalmologist would like to have drawn now as well as if
there is an antiviral that the ophthalmologist would like
started. The ophthalmologist will likely request that a CBC,
CMP, and blood cultures be obtained as well as starting
the patient on an antiviral medication to help prevent
further damage.
• In ophthalmology, the patient will then be evaluated for the
severity of the disease and the course of treatment will
then be initiated. In the severe cases with the necrosis
showing around the entire periphery of the retina, the
patient will likely be taken to the OR for vitreal biopsy(ies)
and given intravitreal antiviral flushing with a vitrectomy
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• The preferred antiviral medication for these injections is
Foscarnet since it reaches the target area with the highest
concentration. This treatment is one that decreases the
progression of the disease damage to the retina as well as
decreases the inflammation that occurs in the vitreous humor.
(Cochrane et al., 2012)
• When it comes to treatment of ARN, early diagnosis is
cornerstone treatment and can lead to the best outcomes.
(Pikkel & Pikkel, 2014)
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